Protective role of Epimedium grandiflorum extract on epididymal tissue and sperm parameters in male rats treated with cisplatin
DOI:
https://doi.org/10.59658/jkas.v12i2.3798Abstract
Given the widespread use of cisplatin and its side effects on health, it was necessary to search for an alternative medicine treatment that reduces the harmful effects of cisplatin. To determine the protective effect of the aqueous extract of Epimedium grandiflorum on cisplatin-induced damage in male rats. The experimental animals include 28 adult male mice were used and randomly divided into four groups of (7) animals each. The duration of the experiment was 57 days. They were treated as follows: negative control group (G1), positive control group (G2) was injected with 2 mg/kg of cisplatin subperitoneally, (G3) was given a daily oral dose of the aqueous extract of Epimedium grandiflorum leaves at a concentration of 350 mg/kg, (G4) received a daily dose of the aqueous extract followed by a weekly injection of cisplatin. Histological changes of the epididymis in group G2 showed little or no interstitial spaces between the epididymal tubules and spermatozoa in the lumen of the tubules, with epididymal tissue damage and some cellular degeneration. In groups G3 and G4, the epididymis showed normal structure with regularity of the epididymal tubules and increased sperm count. Sperm concentration and percentage of motile sperm were decreased, with an increase in the percentage of spermatozoa (non-motile and deformed heads and tails) in G2 compared to (G1, G3, G4) which showed the opposite, so it could be concluded from this study that using the aqueous extract of horny goat weed leaves has been shown to be effective in inhibiting cisplatin-induced damage to the epididymis tissue of male rats.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Copyright (c) 2024 is the Author's article. Published by the Journal of Kerbala for Agricultural Sciences under a CC BY 4.0 license
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing Terms
All articles are published under a Creative Commons License and will be directed to the Creative Commons Attribution 4.0 International License (CC BY 4.0) That permits use, distribution, and reproduction in any medium, provided the original work is properly cited. This license also allows the work to be used for commercial purposes.
Use by both non-commercial and commercial users
This content is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, permitting use by both non-commercial and commercial users. Individual users may access, download, copy, display, and redistribute the articles to colleagues, as well as adapt, translate, and text- and data-mine the content, subject to the following conditions:
- The author's moral rights, including the right of attribution and the right to protect their work from derogatory treatment, are respected.
- Where content in the article is identified as belonging to a third party, users must ensure that any reuse complies with the copyright policies of the owner of that content.
- If the article content is reused for research or educational purposes, users should maintain a link to the appropriate bibliographic citation, including the DOI and a link to the published version on the journal's website.
